James E. Flynn 13D/13G Filings for Werewolf Therapeutics, Inc. (HOWL)

James E. Flynn 13D and 13G filings for Werewolf Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
4:11 pm
Sale
2021-12-3113GWEREWOLF THERAPEUTICS INC
HOWL
James E. Flynn958,125
3.470%
-1,594,662decrease
(-62.47%)
Filing